Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS)
CNY 6.56
(-0.3%)
CNY 6.56
(-0.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 334.81 Million CNY | 24.38% |
| 2022 | 274.43 Million CNY | -23.31% |
| 2021 | 357.85 Million CNY | 34.2% |
| 2020 | 266.65 Million CNY | -20.05% |
| 2019 | 333.51 Million CNY | -15.75% |
| 2018 | 395.89 Million CNY | -21.58% |
| 2017 | 504.83 Million CNY | -0.68% |
| 2016 | 508.28 Million CNY | 7.23% |
| 2015 | 474.01 Million CNY | 22.3% |
| 2014 | 387.6 Million CNY | 25.01% |
| 2013 | 310.06 Million CNY | 20.18% |
| 2012 | 257.99 Million CNY | 35.99% |
| 2011 | 189.71 Million CNY | 73.64% |
| 2010 | 109.25 Million CNY | 81.03% |
| 2009 | 60.35 Million CNY | 70.37% |
| 2008 | 35.42 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 73.83 Million CNY | 13.11% |
| 2024 Q3 | 76.06 Million CNY | -18.69% |
| 2024 Q1 | 65.27 Million CNY | -44.87% |
| 2023 Q4 | 118.41 Million CNY | 31.59% |
| 2023 Q1 | 57.22 Million CNY | -25.79% |
| 2023 FY | 341.33 Million CNY | 24.38% |
| 2023 Q2 | 75.7 Million CNY | 32.3% |
| 2023 Q3 | 89.98 Million CNY | 18.87% |
| 2022 Q3 | 63.03 Million CNY | 4.46% |
| 2022 FY | 274.43 Million CNY | -23.31% |
| 2022 Q1 | 73.93 Million CNY | -22.99% |
| 2022 Q2 | 60.34 Million CNY | -18.38% |
| 2022 Q4 | 77.11 Million CNY | 22.33% |
| 2021 Q2 | 76.15 Million CNY | -4.84% |
| 2021 Q4 | 96 Million CNY | -9.15% |
| 2021 FY | 357.85 Million CNY | 34.2% |
| 2021 Q1 | 80.02 Million CNY | -10.05% |
| 2021 Q3 | 105.66 Million CNY | 38.75% |
| 2020 Q1 | 52.54 Million CNY | -38.18% |
| 2020 FY | 266.65 Million CNY | -20.05% |
| 2020 Q2 | 54.44 Million CNY | 3.61% |
| 2020 Q4 | 88.96 Million CNY | 25.86% |
| 2020 Q3 | 70.68 Million CNY | 29.83% |
| 2019 FY | 333.51 Million CNY | -15.75% |
| 2019 Q4 | 85 Million CNY | -7.92% |
| 2019 Q3 | 92.31 Million CNY | 16.52% |
| 2019 Q2 | 79.22 Million CNY | 2.92% |
| 2019 Q1 | 76.97 Million CNY | -19.46% |
| 2018 Q1 | 89.24 Million CNY | -31.76% |
| 2018 FY | 395.89 Million CNY | -21.58% |
| 2018 Q3 | 112.77 Million CNY | 14.72% |
| 2018 Q4 | 95.57 Million CNY | -15.25% |
| 2018 Q2 | 98.29 Million CNY | 10.15% |
| 2017 Q4 | 130.78 Million CNY | -19.03% |
| 2017 Q2 | 109.14 Million CNY | 5.58% |
| 2017 FY | 504.83 Million CNY | -0.68% |
| 2017 Q3 | 161.52 Million CNY | 47.99% |
| 2017 Q1 | 103.37 Million CNY | -22.46% |
| 2016 Q2 | 107.01 Million CNY | -18.98% |
| 2016 Q4 | 133.31 Million CNY | -1.88% |
| 2016 Q1 | 132.08 Million CNY | 30.19% |
| 2016 Q3 | 135.87 Million CNY | 26.96% |
| 2016 FY | 508.28 Million CNY | 7.23% |
| 2015 Q4 | 101.45 Million CNY | -13.83% |
| 2015 Q3 | 117.73 Million CNY | -12.66% |
| 2015 Q2 | 134.8 Million CNY | 12.31% |
| 2015 FY | 474.01 Million CNY | 22.3% |
| 2015 Q1 | 120.02 Million CNY | 31.91% |
| 2014 FY | 387.6 Million CNY | 25.01% |
| 2014 Q4 | 90.99 Million CNY | -13.46% |
| 2014 Q3 | 105.13 Million CNY | -1.0% |
| 2014 Q2 | 106.2 Million CNY | 24.55% |
| 2014 Q1 | 85.26 Million CNY | 21.55% |
| 2013 Q3 | 92.44 Million CNY | 25.05% |
| 2013 Q1 | 73.55 Million CNY | 0.0% |
| 2013 FY | 310.06 Million CNY | 20.18% |
| 2013 Q4 | 70.14 Million CNY | -24.12% |
| 2013 Q2 | 73.92 Million CNY | 0.49% |
| 2012 FY | 257.99 Million CNY | 35.99% |
| 2011 Q4 | 61.6 Million CNY | 0.0% |
| 2011 FY | 189.71 Million CNY | 73.64% |
| 2010 FY | 109.25 Million CNY | 81.03% |
| 2009 FY | 60.35 Million CNY | 70.37% |
| 2008 FY | 35.42 Million CNY | 0.0% |